Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader Mohamed

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of Particle Therapy|October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
JAMA Network Open|January 23, 2023
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell CarcinomaAnna Lee, Robbie Woods, Amgad Mahfouz, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of Particle Therapy|October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
JAMA Network Open|January 23, 2023
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell CarcinomaAnna Lee, Robbie Woods, Amgad Mahfouz, et al.
Pageof 3